New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in ...

Joseph J. Busch, Jr., M.D. , a board-certified radiologist and Founder of the Busch Center in Alpharetta, GA, will give a presentation titled "Robotic Assisted MRI-Guided Transurethral Ultrasound ...

The Prostate Cancer Foundation (PCF) today announced the launch of the Hästens-PCF Global Health Award, a new initiative designed to advance equitable prostate cancer detection, diagnosis, and care in ...

The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...

An MRI before treatment in men undergoing radical prostatectomy can provide independent prognostic value for oncologic ...

Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all ...

An experimental new treatment slows down the spread of metastatic prostate cancer, postponing the use of hormone treatment by ...

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...

Elidah today announced FDA clearance of Elitone for Men, a non-invasive, at-home treatment designed to help men regain ...

Shares of Oric Pharmaceuticals fell after the company said data from a phase 1b trial of a prostate cancer treatment showed that a larger dose led to higher rates of side effects. Shares were down 22% ...

Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the ...